News for Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International Inc (CRL) has announced a strategic agreement with Singapore General Hospital (SGH) to provide Current Good Manufacturi

Charles River Laboratories International, Inc. (NYSE: CRL) today announced an agreement with Singapore General Hospital (SGH) to provide Current Good Manufactu

Shares of Charles River Laboratories International Inc (CRL) surged 4.59% in mid-day trading on Feb 25. The stock reached an intraday high of $172.45, before

On February 20, 2025, Joseph Laplume, Executive Vice President, Corporate Strategy & Development at Charles River Laboratories International Inc (CRL), sold 4,4

On February 20, 2025, Birgit Girshick, Corporate Executive Vice President & Chief Operating Officer at Charles River Laboratories International Inc (CRL), purch

On February 20, 2025, Charles River Laboratories International, Inc. (CRL) announced that two of its top executives have made significant purchases of the com

The following slide deck was published by Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call February 19, 2025 8:30 AM ETCompany ParticipantsTodd Spencer - Vice...

Charles River Laboratories International, Inc. (CRL) said, for fiscal 2025, the company expects: non-GAAP EPS in a range of $9.10 - $9.60; and revenue to decline in a range of 5.

We recently compiled a list of the 10 AI News Updates on Wall Street's Radar. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

For the month of January, LRT Capital Management strategy return was +7.51%, bringing overall results to +7.51% for the year. Click here to read more.

Shares of Charles River Laboratories International Inc (CRL) surged 4.51% in mid-day trading on Jan 21. The stock reached an intraday high of $171.75, before

Charles River Laboratories International Inc (CRL) has announced the launch of Apolloâ„¢ for CRADL®, a secure cloud-based platform designed to enhance its viva

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of [url="]Apolloâ„¢ for CRADL®[/url], a secure cloud-based platform that

Shares of Charles River Laboratories International Inc (CRL) fell 5.03% in mid-day trading on Jan 16. The stock reached an intraday low of $160.85, before rec

Charles River Laboratories International, Inc. (NYSE: CRL) and Akron Bio (”œAkron”), a leading supplier of critical materials and services for advanced ther

Shares of Charles River Laboratories International Inc (CRL) fell 5.69% in mid-day trading on Jan 14. The stock reached an intraday low of $175.61, before rec

Charles River Laboratories International, Inc. (CRL) recently shared its preliminary financial outlook for 2025 and provided updates on its business segments

Charles River Laboratories International, Inc. (CRL) has announced a significant amendment to its existing credit agreement, enhancing its financial flexibili